Dr. Amy Shapiro was interviewed in American Journal of Hematology as one of several Women Leaders in Hematology. Dr. Shapiro is recognized as a pioneer in her field. You may read the article online; Dr. Shapiro’s interview begins on page 29.
On October 22, IHTC Medical Director, Dr. Amy Shapiro, was interviewed on Inside INdiana Business. To view the program this weekend…
The Indiana Hemophilia and Thrombosis Center (IHTC), Indiana’s only federally recognized Hemophilia Treatment Center, is the first Hemophilia Treatment Center in the U.S. to become a certified medical home by the Accreditation Association for Ambulatory Health Care (AAAHC). This certification recognizes excellence in quality patient-centered health care for organizations that provide medical care on an outpatient basis.
The IHTC hosts Dr. Mwaniki, Medical Officer with AMPATH, from Kenya in August.
Dr. Shapiro receives the 2015 St. Vincent Health Research Symposium Career Achievement in Research Award.
In late April, Emergent BioSolutions, Inc., announced that the US Food and Drug Administration (FDA) has approved IXINITY®, the company’s recombinant factor IX (rFIX) product.
Dr. Gaddy has been awarded the St. Vincent Health 2015 Presidents Award. Read on to see why!
Where are you? Only 30% of patients with bleeding disorders are registered for the free Patient Notification System.
The Federal Government has approved Indiana’s plan to expand Indiana Medicaid through the Health Indiana Plan. For additional information see this article in the Indiana Business Journal.
Indianapolis Monthly’s annual Top Docs issue hit newsstands this month. Read on to see which IHTC physician was selected as one of the top greater Indianapolis docs!